コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 a safe and technically simple liver-specific nerve block.
2 nction as a differential nociceptor-specific nerve block.
3 of patients responded to a greater occipital nerve block.
4 ind leg prior to CIP was used for peripheral nerve block.
5 , but there are no documented liver-specific nerve blocks.
6 le the ON was involved in only one of the 34 nerve blocks.
7 rates of peripheral compared with neuraxial nerve blocks.
8 em to bring better evidences than those with nerve blocks.
9 for pain management including utilization of nerve blocks.
10 onitoring options when performing peripheral nerve blocks.
11 usage of ultrasound guidance for peripheral-nerve blocks.
12 uide the placements of continuous peripheral nerve blocks.
13 o different from single injection peripheral nerve blocks.
14 ng and improving the use of lower peripheral nerve blocks.
15 further increased the utility of peripheral nerve blocks.
16 improve the performance of lower peripheral nerve blocks.
17 and measurement of efficacy for sympathetic nerve blocks.
18 data, most nerve blocks were effective (107 nerve blocks [57.5%]with >=50% pain reduction), quick (m
19 (median [IQR] time, 15 [12-20] minutes; 113 nerve blocks [90.0%] <25 minutes), and safe (1 minor hem
20 evaluation, therapy may include medication, nerve blocks, active physical therapy, behavioural inter
21 ision model by peri-incisional and popliteal nerve block administration combined with mechanical test
23 There is an urgent clinical need to develop nerve-blocking agents capable of inducing long duration
27 ble nerve stimulator that enables electrical nerve block and associated pain mitigation without these
28 ketamine, and techniques such as peripheral nerve block and local infiltration analgesia have become
29 models illustrate capabilities for complete nerve block and other key features of the technology.
32 s from 198 consecutively performed foraminal nerve blocks and foraminal epidural injections in the th
33 lies on subjective symptoms and responses to nerve blocks and Onabotulinum toxin A (Botox) injections
34 eroids in oral form or for greater occipital nerve block, and preventive treatments include verapamil
37 bitors, gabapentinoids, ketamine, peripheral nerve blocks, and local infiltration analgesia benefit p
39 lgesics and ambulatory continuous peripheral nerve blocks are encouraged to achieve adequate postoper
42 luated the utility and efficiency of sciatic nerve block as an alternative method to relieve severe r
43 esia, regional analgesia, critically ill and nerve blocks, as well as a search of the Cochrane Librar
44 on who underwent unilateral versus bilateral nerve blocks at a single institution from 2017 to 2019 w
45 interest is the use of continuous peripheral nerve blocks at home and their potential effect upon hos
47 asing interest in lower extremity peripheral nerve blocks because of their potential advantages and c
48 movement-induced afferent input by saphenous nerve block before, but not after, hindlimb movement blo
49 extremely potent, and can provide very long nerve blocks but the duration is limited by the associat
53 ere we show that prolonged sensory-selective nerve block can be produced by specific concentrations o
59 linical studies on neuraxial anaesthesia and nerve blocks did not bring so far a strong conclusion to
60 ree sequential SDL injections resulting in a nerve block duration of 18.1 +/- 3.4 d delayed the onset
62 ferent cVNS enabled by complete afferent KES nerve block enhances the anti-inflammatory benefits of c
66 ity of paired efferent cVNS and afferent KES nerve block for achieving selective efferent cVNS, speci
67 received ultrasound-guided popliteal sciatic nerve block for the relief of severe rest pain during en
68 studies into the clinical use of peripheral nerve blocks for anesthesia and postoperative analgesia
69 se polymers produced a range of durations of nerve block, from several hours to 3 days, with minimal
70 loss was statistically greater in the vagal nerve block group (P = .002 for treatment difference in
71 At 12 months, 52% of patients in the vagal nerve block group achieved 20% or more excess weight los
72 In the intent-to-treat analysis, the vagal nerve block group had a mean 24.4% excess weight loss (9
73 ated serious adverse event rate in the vagal nerve block group was 3.7% (95% CI, 1.4%-7.9%), signific
74 he adverse events more frequent in the vagal nerve block group were heartburn or dyspepsia and abdomi
78 ss for anesthesia providers, many peripheral-nerve blocks have become quite amenable to being placed
82 tivity in the field of continuous peripheral nerve blocks in the ambulatory setting and places it in
83 ents with rare sensory disorders, as well as nerve blocks in typical individuals, to probe the neural
85 rm deprivation of sensory input by ischaemic nerve block (INB) leads to functional reorganization in
87 plasticity model, in which forearm ischemic nerve block (INB) was combined with low-frequency repeti
88 gesia with continuous epidural or peripheral nerve block infusions, judicious opioids, acetaminophen,
89 d from eosinophils to airway parasympathetic nerves blocks inhibitory M(2) muscarinic receptors on th
90 e sessions, tasks were preceded by bilateral nerve block injections to the sensory branches of the tr
94 ations associated with continuous peripheral nerve blocks is very low and probably no different from
96 e reduced TTX systemic toxicity and produced nerve block lasting 9.7+/-2.0 h, in comparison to 1.6+/-
98 p block (PNGB) and lateral femoral cutaneous nerve block (LFCNB) on block range and analgesia as well
99 sibilities afforded by the use of peripheral nerve blocks mainly consist of prolonged analgesia, sele
100 uroprosthetic devices, whereas the on-demand nerve-blocking mechanism could offer effective clinical
101 in perfusion of [(14)C] sucrose; bupivacaine nerve block of CIP caused an attenuation of [(14)C] sucr
102 dies in humans, the effect of a differential nerve block on itch produced by intradermal insertion of
103 t the functional inhibition of the occipital nerve block on trigeminal nociceptive activity is likely
104 he differences between plasticity induced by nerve block or damage versus that induced by experience.
106 n-relieving treatments, including peripheral nerve block or spinal clonidine, an alpha2-adrenergic ag
111 of local anesthetic required to accomplish a nerve block, reducing the potential for systemic toxicit
112 2004 using the search terms critically ill, nerve blocks, regional analgesia, and regional anesthesi
113 s recorded in the National Ultrasound-Guided Nerve Block Registry from January 1, 2022, to December 3
114 ded data from the National Ultrasound-Guided Nerve Block Registry, a retrospective multicenter observ
118 There is increasing interest in peripheral nerve blocks, single or continuous, mainly for periopera
119 the use of ambulatory continuous peripheral nerve blocks such as the interscalene, infraclavicular a
120 barriers to the widespread use of peripheral nerve block techniques across multiple disciplines.
123 wer limb mechanics with and without a tibial nerve block that prevented contraction of these muscles.
124 oscopically directed thoracic intraforaminal nerve blocks that showed few complications and anatomica
125 catheters for the performance of continuous nerve blocks, the use of adjuvants to extend the duratio
126 tients with morbid obesity, the use of vagal nerve block therapy compared with a sham control device
129 rn to prefer a context paired with saphenous nerve block to elicit pain relief (i.e., conditioned pla
130 with kilohertz electrical stimulation (KES) nerve block to preferentially activate efferent pathways
132 the safety and efficacy of novel peripheral nerve blocks, transversus abdominis plane and ultrasound
134 greatly increasing the number of triggerable nerve blocks (up to nine triggerable events upon a singl
135 knowledge-to-practice intervention improved nerve block uptake, and nerve blocks were quick, safe, a
137 rves to display the most clinically relevant nerve blocks utilized in the perioperative setting.
139 jectives were to determine whether the vagal nerve block was superior in mean percentage excess weigh
140 ve pilot study, 12 patients who received the nerve block were compared with a control group regarding
141 ve blocks with pain effectiveness data, most nerve blocks were effective (107 nerve blocks [57.5%]wit
142 ntervention improved nerve block uptake, and nerve blocks were quick, safe, and mostly effective.
144 were randomized to receive ultrasound-guided nerve block with a 40 mL solution of local anesthetic an
145 ndomised study the influence of an occipital nerve block with lidocaine 1% on neuronal activation in
146 associate the effects of a lidocaine cornual nerve block with the location and pattern of a visual st
147 similar compounds can provide very prolonged nerve blocks with minimal systemic and local toxicity.